Stem Inc - Class A (STEM) Stock Price

12.75 ▲ +0.76 (+6.34%)
Open: 12.27 Vol: 253.12K Day's range: 11.76 - 12.95 Feb 06, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
STEM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL BUY SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 12.79▼ 12.78▲ 12.64▲ 14.01▼ 17.06▼
MA10 12.79▼ 12.64▲ 12.41▲ 15.43▼ 17.25▼
MA20 12.75▲ 12.40▲ 12.94▼ 17.25▼ 18.37▼
MA50 12.49▲ 13.55▼ 14.67▼ 17.27▼ 13.79▼
MA100 12.72▲ 14.93▼ 16.72▼ 18.64▼ 16.03▼
MA200 13.90▼ 17.11▼ 17.07▼ 15.08▼ 82.13▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.007▼ 0.153▲ 0.136▲ -0.654▼ -0.666▼
RSI 54.895▲ 48.286▼ 38.460▼ 30.612▼ 42.423▼
STOCH 55.560     85.073▲ 71.850     9.169▼ 41.762    
WILL %R -39.344     -10.909▲ -52.078     -89.274▼ -90.443▼
CCI 63.704     95.151     81.090     -146.188▼ -182.228▼
Latest Filters Detected On STEM
▲ RSI $STEM RSI(14) Crossed Above 30 Set Alert
▼ MA $STEM MA(20) Crossed Below MA(50) Set Alert
▲ GAP $STEM Open Gap Up %2 Set Alert
CDL $STEM Harami Candlestick Pattern Detected Set Alert
Stem Inc - Class A News
Stem Cell Specialist PrimeGen Takes SPAC Track to Nasdaq
Thursday, February 05, 2026 05:14 AM
The SPAC agreement values PrimeGen US at $1.5 billion in equity and gives it capital to advance its pre-clinical triple-activated mesenchymal stem cell pipeline into the clinic.
Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq
Wednesday, February 04, 2026 06:15 AM
Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the public markets. | Stem cell therapy biotech PrimeGen US is taking the ...
Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging
Tuesday, December 02, 2025 06:15 AM
MIAMI, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic ...
STEM historical stock data
date open high low close volume
06/02/26 12.27 12.95 11.76 12.75 253,118
05/02/26 13.92 14.0943 11.8001 11.99 436,465
04/02/26 15.41 15.49 13.6801 14.37 229,672
03/02/26 16.05 16.23 14.412 15.36 287,130
02/02/26 15.45 16.06 15.1868 15.60 188,010
30/01/26 16.39 16.88 15.50 15.60 217,297
29/01/26 17.01 17.135 16.40 16.62 165,345
28/01/26 17.60 17.965 16.94 16.94 134,441
27/01/26 17.96 18.27 17.06 17.31 143,760
26/01/26 18.33 18.33 17.23 17.77 264,324
Quote Details
52wk Low:5.814
52wk High:32.23
Vol:253.12K
Avg Vol(3m):3.6M
1Y Chng:+29.39%
1M Chng:-22.21%
Add to Watch List
More Information
Index N/A
Market Cap. 100.60M